1538-09-6 Penicillin G benzathine salt with 0.2% Polysorbate 80 AKSci X2930
 
 
Loading Please Wait...
  X2930    
Penicillin G benzathine salt with 0.2% Polysorbate 80
, 98% (HPLC)
 
Benzathine benzylpenicillin with 0.2% Polysorbate 80




IDENTITY
CAS Number:1538-09-6
MDL Number:MFCD00079284
MF:C16H20N2.2C16H18N2O4S
MW:909.13
EINECS:216-260-5
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:98% (HPLC)
Physical Form (at 20°C):Solid
Melting Point:133-136°C
Long-Term Storage:Store long-term in a cool, dry place
Note:Contain 0.2% Polysorbate 80
DOT/IATA TRANSPORT INFORMATION
Not hazardous material

REVIEW

 Benzathine benzylpenicillin is a form of penicillin antibacterial also known as benzathine penicillin. It is slowly absorbed into the circulation after intramuscular injection and hydrolysed to benzylpenicillin in vivo. It is the drug-of-choice when prolonged low concentrations of benzylpenicillin are required and appropriate, allowing prolonged antibiotic action over 2-4 weeks after a single IM dose. Specific indications for benzathine penicillin include prophylaxis of rheumatic fever and early or latent syphilis. The benzylpenicillin inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs). This inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.

REFERENCES
[1]Elias, William; Price, Alison H.; Merrion, H. Joseph N,N'-Dibenzylethylenediamine penicillin: a new repository form of penicillin Antibiotics and Chemotherapy (Washington, D. C.) (1951), 1, 491-8.
[2] Szabo, J. Lester; Edwards, Charles D.; Bruce, Wm. F. N,N'-Dibenzylethylenediamine penicillin: preparation and properties Antibiotics and Chemotherapy (Washington, D. C.) (1951), 1, 499-503.
[3] Fletcher, A. P.; Knappett, C. R. N,N'-Dibenzylethylenediamine penicillin: a new repository form of penicillin British Medical Journal (1953), 1953, I, 188-9.
[4] Dupin N, Farhi D. Syphilis.Presse Med. 2013 Apr;42(4 Pt 1):446-53.
[5] De Holanda E Silva KG, Barratt G, De Oliveira AG, Do Egito ES. Trends in rheumatic fever: clinical aspects and perspectives in prophylactic treatments. Expert Opin Drug Deliv. 2012 Sep;9(9):1099-110.
[6] Cuddy PG.Benzathine penicillin G in the treatment of neurosyphilis. Drug Intell Clin Pharm. 1982 Mar;16(3):205-10.
[7] Taranta A, Gordis L. The prevention of rheumatic fever: opportunities, frustrations, and challenges. Cardiovasc Clin. 1972;4(3):1-10.

GLOBALLY HARMONIZED SYSTEM (GHS)

Pictograms

Signal Word
Danger

Hazard Statements
H302; H334

Precautionary Statements
P261; P264; P270; P285; P301+P312; P304+P341; P330; P342+P311; P501


RELATED PRODUCTS
P691Penicillin G benzathine salt with 1% Lecithin
X2930Penicillin G benzathine salt with 0.2% Polysorbate 80

Current as of April 16, 2024


Download SDS Request COA

All products are stocked and shipped from San Francisco Bay Area, California, USA.

⚠️
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.



CATEGORIES

 APIs and Bioactives > Antibacterials, Penicillins


PubChem
  @PubMed